Recent Quotes (30 days)

You have no recent quotes
chg | %

Healthcare News

Showing stories 1 - 10 of about 70   
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing ...
ATLANTA—Johnson & Johnson's Janssen unit has found plenty of success moving Darzalex earlier and earlier into multiple myeloma therapy, and it now has data that could help it win a coveted spot in first-line treatment.
CertaDose Wins Johnson & Johnson Innovation Award for Advancing Safety in ...
DENVER & SAN ANTONIO--(BUSINESS WIRE)--One of the most common mistakes made in emergency rooms is giving children the wrong dose of medicine.
Dividend stats on Johnson & Johnson
Johnson & Johnson's record of rising dividend payments dates back to the 1960s, and the company has done an excellent job of producing consistent dividend growth regardless of overall macroeconomic conditions or the particular environment the ...
The Outlook For Johnson & Johnson's Immunology Drug Business
Johnson & Johnson's immunology portfolio, which primarily consists of Remicade, Simponi and Stelara, accounts for around 15% of the company's value, according to our estimates.
As Johnson & Johnson holds off US biosims, Remicade's European ...  FiercePharma
Johnson & Johnson unites with key local organisations to fight HIV/AIDS
The fight against HIV/AIDS received a major boost as Johnson & Johnson joined forces with Ghana AIDS Commission, Planned Parenthood Association of Ghana and the Youth Action Movement to engage the local communities of Koforidua in targeted HIV/AIDS ...
Johnson & Johnson's JLABS looks east as it lands in Shanghai
Now well established across the U.S. and Canada, J&J's biotech incubator system has expanded into Asia with its first center in China.
Johnson & Johnson Innovation Announces Launch of JLABS @ Shanghai in ...  PR Newswire (press release)
Johnson & Johnson, Sanofi top 'Good Pharma' trial transparency ranking with ...
Bioethics International's latest study of clinical transparency for new drugs studied meds approved by the FDA in 2014. Share Facebook Twitter LinkedIn Email Print.
Johnson & Johnson (JNJ) Management Presents at Citi Global Healthcare Conference
Thank you for joining us. I'm delighted to introduce keynote speaker, Joaquin Duato, who is the Chairman of Pharmaceuticals at J&J.
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (Symbol: JNJ).
Pfizer Inc. Announces (i) Private Exchange Offer for its 6.500 per cent. Notes ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) (“Pfizer”) today announced that it has commenced a private offer to exchange (the “Exchange Offer”) any and all of its outstanding �1,500,000,000 6.500 per cent.